NCT06937255 Dynamic Assessment of the Risk for Language and Reading Disorders in Monolingual and Multilingual Children
| NCT ID | NCT06937255 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Eugenio Medea |
| Condition | Developmental Dyslexia |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-04-03 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2023-04-03 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project represents the completion of a part of the recently concluded European project MultiMind, in which a computer platform called MuLiMi was developed and validated. The platform hosts screening tests for the identification of the risk of Language and Learning Disorders in preschool and primary school children, respectively. The aim is to validate the Dynamic Assessment (DA) tests (a first test assessing the capacity to learn new words for preschool children and a second one assessing the capacity to learn a new spelling code for school-age children) in a population of monolingual and bilingual children attending preschool and primary school. The main goal of the study is to complete the validation of the two Dynamic Assessment tests implemented in the MuLiMi platform developed for the MultiMind project.
Eligibility Criteria
Inclusion Criteria: * age 4-6 years (Kindergarten) or 7-9 years (Primary school); * Attendance at an Italian-language school in Italy or Switzerland/Germany. Additional inclusion criteria for the multilingual group only: * (i) At least one parent speaks at least one language other than Italian in the family; * (ii) Continuous exposure to the Italian language for at least two years. Exclusion Criteria: * Intellectual disability, major psychopathological disorders, exposure to Italian language for less than two years.
Contact & Investigator
Maria Luisa Lorusso, Ph.D
PRINCIPAL INVESTIGATOR
IRCCS E. Medea
Frequently Asked Questions
Who can join the NCT06937255 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 9 Years, studying Developmental Dyslexia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06937255 currently recruiting?
Yes, NCT06937255 is actively recruiting participants. Contact the research team at marialuisa.lorusso@lanostrafamiglia.it for enrollment information.
Where is the NCT06937255 trial being conducted?
This trial is being conducted at Bosisio Parini, Italy.
Who is sponsoring the NCT06937255 clinical trial?
NCT06937255 is sponsored by IRCCS Eugenio Medea. The principal investigator is Maria Luisa Lorusso, Ph.D at IRCCS E. Medea. The trial plans to enroll 150 participants.